In-Patient detox grant 2025

Location

South West England:

Description

As part of a Central Government investment of money to reduce the harms caused by substance use and to tackle related crime, all local authorities have been allocated grants to improve drug treatment services. These grants were initially for one year (2021-22) but were extended for a further three years (2022-25) with confirmation of allocations made on an annual basis. These grants are now due to be extended for a further year (25-26) although we are still waiting for final confirmation, it is expected that services will commence on 1 April 2025 providing a seamless continuation of the services funded from the previous grants. The grants are ring fenced and the Inpatient Detoxification (IPD) Grant has to be used to fund inpatient drug and alcohol detoxification services, predominately medically managed detoxifications. A condition of receiving the IPD grant is that LA's have to join together to form a consortium. North Somerset has formed a consortium with six other local authorities (Bristol, Bath and North-East Somerset, Gloucestershire, Somerset, South Gloucestershire and Swindon). North Somerset Council acts as the Lead Authority for the consortium and is therefore responsible for holding and manging the Inpatient Grant on behalf of the other consortium members. The grant allocated for each of the consortium members is provided below: • North Somerset - £36,161 (8.0% of the Consortium total) • Bristol - £140,323 (31.2% of the Consortium total) • Bath and North-East Somerset - £40,334 (9.0% of the Consortium total) • Gloucestershire - £95,122 (21.2% of the Consortium total) • South Gloucestershire - £27,916 (6.2% of the Consortium total) • Somerset - £70,484 (15.7% of the Consortium total) • Swindon - £39,191 (8.7% of the Consortium total) • Total - £449,530 The IPD Grant for North Somerset Consortium is £449,530.

Total Quantity or Scope

In-Patient detox grant

Award Detail

Award Criteria

CPV Codes

• 85312500 - Rehabilitation services

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

Other Information

Due to the limited availability of medically managed detoxification facilities in the South West and particularly the footprint area covered by the consortium, there are only two facilities available (ACER unit; Bristol operated by AWP NHS Trust and Broadway Lodge; Weston-super-Mare), therefore there are not any other alternatives available. It is therefore proposed to continue to block purchase bed capacity at these two units in addition to fund a part-time system co-ordinator through our treatment provider (We Are With You) to manage referrals and ensure maximum bed occupancy. To be awarded to 2 existing suppliers under the Provider Selection Regime - Direct Award Process C Duration: 01..04.2025 - 31.03.2026 ** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 24 March 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: kate.williams@n-somerset.gov.uk Award decision makers: Matt Lenny Sam Hayward Fiona Dixon The relative importance of the Key Criteria were set as Social Value - pass/fail, Value - Pass/ fail (providers accept rate offered), Improving Access - 50%, Integration/collaboration - 25%, Quality/Innovation - 25% Current providers were Satisfactory or above in all Key Criteria. No conflicts of interest were identified